Real-time enrollment status for this b-cell malignancy clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 5:22 PM UTC
| NCT Number | NCT05602363 |
| Recruiting Status | Recruiting |
| Condition | B-cell Malignancy |
| Phase | PHASE1 |
| Target Enrollment | 120 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Carna Biosciences, Inc. |
| Last Updated on CT.gov | December 10, 2025 (Dec 10, 2025) |
As of August 27, 2026: Clinical trial NCT05602363 is currently recruiting participants. This phase1 study for b-cell malignancy is actively seeking new participants at 13 locations across the United States. The study is sponsored by Carna Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05602363 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05602363 was last updated Dec 10, 2025 (December 10, 2025). HelloStudys verifies this status automatically.